Compare NTHI & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTHI | WHF |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.5M | 162.5M |
| IPO Year | N/A | 2012 |
| Metric | NTHI | WHF |
|---|---|---|
| Price | $8.20 | $7.01 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.75 |
| AVG Volume (30 Days) | 66.3K | ★ 181.8K |
| Earning Date | 02-19-2026 | 03-06-2026 |
| Dividend Yield | N/A | ★ 14.96% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | $59,990.00 | ★ $76,339,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.31 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.20 | $6.39 |
| 52 Week High | $25.00 | $11.31 |
| Indicator | NTHI | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 44.20 | 48.63 |
| Support Level | $8.11 | $6.81 |
| Resistance Level | $10.19 | $7.09 |
| Average True Range (ATR) | 0.86 | 0.16 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 12.92 | 51.19 |
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.